Search
for
Sort by
Research 451–480 of 1000+
- Alopecia
- Alopecia areata
- Acquired scalp alopecia. Part I: A review
- Isoniazid-induced Alopecia: A Rare Entity
- Lichen Planopilaris
- Molecular mechanisms of androgenetic alopecia
- Frontal fibrosing alopecia: a survey in 16 patients
- Clinical Approach to the Patient With Alopecia
- Alopecia
- Psoriasis and Alopecia: Unveiling the Links
- Prevalence and factors associated with telogen effluvium in adult females at Makkah region, Saudi Arabia: A retrospective study
- Cicatricial Alopecia
- Comparative Analysis of Trichoscopic Features in Women with Androgenetic Alopecia and Telogen Effluvium
- Abstracts Pt.30
- Frontal fibrosing alopecia, clinical and histopathological characteristics of mexican patients: an original research study and review of literature
- Peculiarities of clinical course and diagnostic of alopecia areata with comorbidity. Clinical observations
- Telogen Effluvium – a review of the science and current obstacles
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia
- Trichoscopic findings in various alopecias at tertiary referral center: A cross-sectional study
- Female pattern alopecia: current perspectives
- Alopecia Areata Mimicking Frontal Fibrosing Alopecia
- Skin Manifestations of Rheumatological Diseases
- Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
- Frontal fibrosing alopecia: a disease that remains enigmatic
- Expert consensus recommendations on appropriate serological testing for the chief complaint of alopecia
- Clinicopathologic Case 2: Multiple Intraoral White Lesions in a 55-year-old Female
- Effects of age and sex on the comorbidities of alopecia areata: A cross‐sectional hospital‐based study
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy